Thrombopoietin Level Predicts Response to Treatment with Romiplostim in Chemotherapy-Induced Thrombocytopenia

被引：0
|
作者：
Song, Andrew B. [1 ,2 ]
Goodarzi, Katayoon [1 ,3 ]
Leaf, Rebecca Karp [1 ,3 ]
Kuter, David J. [1 ,4 ]
Al-Samkari, Hanny [1 ,5 ]
机构：
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Div Hematol, Boston, MA 02114 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Hematol Div, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-145931
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
584
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [21] Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
    Shin, Jiwon
    Kim, Min-Jung
    Quan, Xingguo
    Kim, Ji Woong
    Lee, Sukmook
    Park, SaeGwang
    Jeong, Jee-Yeong
    Yea, Kyungmoo
    BMC CANCER, 2023, 23 (01)
  • [22] Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia
    Vadhan-Raj, S
    SEMINARS IN HEMATOLOGY, 2000, 37 (02) : 28 - 34
  • [23] Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial
    Soff, Gerald A.
    Miao, Yimei
    Devlin, Sean M.
    Mantha, Simon
    Mones, Jodi V.
    Li, Valery J.
    Abou-Alfa, Ghassan K.
    Cercek, Andrea
    Kemeny, Nancy
    Parameswaran, Rekha
    BLOOD, 2017, 130
  • [24] The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors
    Al-Samkari, Hanny
    Marshall, Ariela L.
    Goodarzi, Katayoon
    Kuter, David J.
    HAEMATOLOGICA, 2018, 103 (04) : E169 - E172
  • [25] Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours
    Zhang, Xia
    Chuai, Yunhai
    Nie, Wei
    Wang, Aiming
    Dai, Guanghai
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
  • [26] Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia
    Song, Andrew B. B.
    Al-Samkari, Hanny
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (05) : 365 - 375
  • [27] Treating Chemotherapy-Induced Thrombocytopenia: Is It Time for Oncologists to Use Thrombopoietin Agonists?
    Hassan, Mojibade N.
    Waller, Edmund K.
    ONCOLOGY-NEW YORK, 2015, 29 (04): : 295 - 296
  • [28] Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy-induced thrombocytopenia
    Akahori, H
    Shibuya, K
    Obuchi, M
    Nishizawa, Y
    Tsuji, A
    Kabaya, K
    Kusaka, M
    Ohashi, H
    Tsumura, H
    Kato, T
    Miyazaki, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (04) : 722 - 728
  • [29] Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care
    Merjaneh, Nawal
    Young, Jennifer
    Mangoli, Avani
    Olsen, Mallery
    Setty, Bhuvana
    Lane, Adam
    Nagarajan, Rajaram
    Pressey, Joseph G.
    Turpin, Brian
    PEDIATRIC BLOOD & CANCER, 2022, 69 (07)
  • [30] Single-Center Experience with Romiplostim for Management of Chemotherapy-Induced Thrombocytopenia (CIT)
    Miao, Jennifer
    Leblebjian, Houry
    Fowler-Scullion, Bridget
    Parnes, Aric
    BLOOD, 2016, 128 (22)
12345